class = “releaseDateline”>

Nearly 30 million people with varicose veins in the United States in 2005 affected. Minimally invasive surgery (MIS) are encouraging process to treatment for patients nona search?? Life threatening varices. A new report from Millennium Research Group (MRG), a growing number of Americans is endovenous laser ablation for MIS (ELA) and endovenous radiofrequency ablation (ERFA) treatments in 2005 sales of nearly million opt into the process. Better Medicare and private reimbursement, with strong marketing campaigns in the industry on the road and recorded volumes of procedures saved in the next five years combined, and allow the U.S. market to nearly 0 million in 2010.

In the next five years will dominate most of the ELA process saphenous (GSV) reflux treatment market. The technology is already more popular than ERFA and even the traditional surgical stripping in 2007, surpassing independently of the introduction of minimally invasive instruments and techniques for the stripping Lamaitre and Smith & Nephew (SNN). In consequence of this increasing dominance, the PA market significant revenues from the disposable kits for each GSV ablation will generate required. Also driving market growth is composed of the refund and better visibility of the patient population through comprehensive sales support and marketing for doctors purchase PA systems, each of these factors will contribute more to an annual growth rate of almost 20% of the market ELA.


Non-GSV

treatment of varicose veins will be led by sclerotherapy procedures over the next five years, mainly because of the new FDA-approved Sotradecol Bioniche. Durchleuchtet powered phlebectomy made (TIP) process that led to Smith & Nephew, also effective varicose vein removal options available and will have a modest acceptance in the U.S. market.

mrga? s includes U.S. markets for treatment of varicose veins apparatus 2006 analyzes ERFA, ELA, surgical stripping, phlebectomy, sclerosis and markets. The report also includes established and emerging competitors, including AngioDynamics (ANGO), Biolitec, Johnson & Johnson (JNJ) subsidiary, Codman, CoolTouch, Diomede (DIO), Dornier, Lamaitre Smith & Nephew (SNN), Vascular Solutions (Vasc ) and VNUS (VNUS).

an important source of competitive intelligence MRG is now the largest provider of medical research equipment market in the world. Located in Toronto, Canada, MRG covers global markets and is the source of the reports of many new products.

Contact:

Marlon

Deogracias

+1 (416) 364-7776 ext. > 165

P

###
clear = “all”
Treatment of varicose veins